Zanthoxylum alkylamides ameliorate protein metabolism disorder in STZ-induced diabetic rats. - Wikidata - awgldk - TriplyDB

Zanthoxylum alkylamides ameliorate protein metabolism disorder in STZ-induced diabetic rats.

Zanthoxylum alkylamides ameliorate protein metabolism disorder in STZ-induced diabetic rats.

http://www.wikidata.org/entity/Q33654613

about

Polyunsaturated fatty acid amides from the Zanthoxylum genus - from culinary curiosities to probes for chemical biology.

P2860

Q47752302-EED0BBA7-906C-4F68-8913-9F4FAC6E146B

P2860

Zanthoxylum alkylamides ameliorate protein metabolism disorder in STZ-induced diabetic rats.

http://www.wikidata.org/entity/Q33654613

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

name

Zanthoxylum alkylamides amelio ...... in STZ-induced diabetic rats.

@ast

Zanthoxylum alkylamides amelio ...... in STZ-induced diabetic rats.

@en

type

label

Zanthoxylum alkylamides amelio ...... in STZ-induced diabetic rats.

@ast

Zanthoxylum alkylamides amelio ...... in STZ-induced diabetic rats.

@en

prefLabel

Zanthoxylum alkylamides amelio ...... in STZ-induced diabetic rats.

@ast

Zanthoxylum alkylamides amelio ...... in STZ-induced diabetic rats.

@en

P1433

Q33654613-1863AC69-98F3-4792-967F-297EE1B047BD

P1476

Q33654613-37ECA52A-49AB-42DB-8A5F-F144DDA9038F

P2093

Q33654613-21A639BC-6131-4E9E-A902-DFFAC0B864F3

Q33654613-5F3FA51E-9EB6-4687-8931-7DBF68D01D61

Q33654613-94018F40-83CC-4EBC-BDAC-4A8608D99861

Q33654613-A1F1BEFB-1483-433B-B226-29F68460A480

Q33654613-D4372A0B-19B4-44A8-B59B-37709EB81087

Q33654613-EACC18D7-AEE9-4311-A882-D84A819DC598

P2860

Q33654613-0E30370A-B46D-4A36-BC06-46DE20EF12B4

Q33654613-0FFF8D6C-1822-4BBD-AA99-F523B701960E

Q33654613-1E0395D3-9E62-404D-A105-049003B22A35

Q33654613-21B4E592-90A7-417F-9CA5-8A426DADB46D

Q33654613-2F0995E1-14F1-4DA9-AFA6-1BFF44EBF5B3

Q33654613-313F62BC-AA5A-4EA7-835E-3D7A5FFF77E1

Q33654613-3A9221EE-ED2C-4CF3-AB6D-EA78EDB94407

Q33654613-414610D9-BD3D-45A5-8E3E-45AB4EAD79B8

Q33654613-44A2D2C8-0F71-42FC-BCA3-C6A05C026C30

Q33654613-49C94E10-EEB3-4F29-AF87-058507B1E1D6

P304

Q33654613-0F330E59-EF24-4D31-8D98-52824687E7FD

P31

Q33654613-9D2CA0D8-FEF0-427C-8B70-2B3FE83F96B1

P356

Q33654613-73D2F70E-1AB1-4C92-874E-89A0E3D5F319

P433

Q33654613-DC491F93-6DCF-4A01-8FA9-BBD1FEE4D6D0

P478

Q33654613-40C5E9F5-65AC-441F-8C52-9D6B672B94DE

P577

Q33654613-70C9B639-C7F8-49AF-AC93-447BE158B340

P698

Q33654613-3EA57B8A-CF65-4D9F-8520-96EADC11C49D

P932

Q33654613-0F51A525-A1EF-4185-BBCC-4CC8F6435B67

P356

P1433

Journal of Molecular Endocrinology

P1476

Zanthoxylum alkylamides amelio ...... in STZ-induced diabetic rats.

@en

P2093

Jianquan Kan

http://www.w3.org/2001/XMLSchema#string

Jing Guo

http://www.w3.org/2001/XMLSchema#string

Tingyuan Ren

http://www.w3.org/2001/XMLSchema#string

Xuejuan Xia

http://www.w3.org/2001/XMLSchema#string

Yongbo Ding

http://www.w3.org/2001/XMLSchema#string

Yuping Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms. Direct and indirect effects on nuclear/cytoplasmic shuttling and DNA binding

Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX.

Protection against T1DM-Induced Bone Loss by Zinc Supplementation: Biomechanical, Histomorphometric, and Molecular Analyses in STZ-Induced Diabetic Rats

Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism

Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy

The mERG1a channel modulates skeletal muscle MuRF1, but not MAFbx, expression.

Decreased neuronal bursting and phase synchrony in the hippocampus of streptozotocin diabetic rats

Insulin-like growth factor-I E-peptide activity is dependent on the IGF-I receptor.

Oral antihyperglycemic therapy for type 2 diabetes: scientific review.

The coordinate cellular response to insulin-like growth factor-I (IGF-I) and insulin-like growth factor-binding protein-2 (IGFBP-2) is regulated through vimentin binding to receptor tyrosine phosphatase β (RPTPβ)

P304

113-125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1530/JME-16-0218

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28100702

http://www.w3.org/2001/XMLSchema#string

P932

5424265

http://www.w3.org/2001/XMLSchema#string